BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27152284)

  • 1. Prevalence and Epidemiological Factors Involved in Cellulitis in Korean Patients With Lymphedema.
    Park SI; Yang EJ; Kim DK; Jeong HJ; Kim GC; Sim YJ
    Ann Rehabil Med; 2016 Apr; 40(2):326-33. PubMed ID: 27152284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erysipelas and lymphangitis in patients undergoing lymphedema treatment after breast-cancer therapy.
    Pereira de Godoy JM; Azoubel LM; Guerreiro Godoy Mde F
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Jun; 18(2):63-5. PubMed ID: 19588059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, microbiological epidemiology and recommendations for management of cellulitis in extremity lymphedema.
    Rodriguez JR; Hsieh F; Huang CT; Tsai TJ; Chen C; Cheng MH
    J Surg Oncol; 2020 Jan; 121(1):25-36. PubMed ID: 31264724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent vulvar lymphangitis cured with vulvectomy in a cervical carcinoma patient: a case report.
    Micha JP; Goldstein BH; Rettenmaier MA; Tinnerman-Minailo EJ; Brown JV; McClellan SN; Bock BV
    J Reprod Med; 2008 Apr; 53(4):299-301. PubMed ID: 18472655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Dermal Hypoechogenicity and Cellulitis History in Patients with Lower Extremity Lymphedema: A Cross-Sectional Observational Study.
    Dai M; Minematsu T; Ogawa Y; Kawamoto A; Nakagami G; Sanada H
    Lymphat Res Biol; 2022 Aug; 20(4):376-381. PubMed ID: 34762544
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellulitis risk factors for patients with primary or secondary lymphedema.
    Vignes S; Poizeau F; Dupuy A
    J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):179-185.e1. PubMed ID: 33957278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episodic dermatolymphangioadenitis (DLA) in patients with lymphedema of the lower extremities before and after administration of benzathine penicillin: a preliminary study.
    Olszewski WL
    Lymphology; 1996 Sep; 29(3):126-31. PubMed ID: 8897357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of recurrent lymphangitis complicating lymphedema.
    Babb RR; Spittell JA; Martin WJ; Schirger A
    JAMA; 1966 Mar; 195(10):871-3. PubMed ID: 12608187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors Associated with Adverse Outcomes after Ablative Surgery for Lymphedema.
    Kuruvilla AS; Shroyer ALW; Li X; Yang J; Mulay SR; Agha SM; Bellis RM; Kohli HK; Tannous HJ; Krajewski A
    J Reconstr Microsurg; 2023 Mar; 39(3):214-220. PubMed ID: 36162422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangitis and refractory lymphedema after treatment with topical cantharidin.
    Stazzone AM; Borgs P; Witte CL; Witte MH
    Arch Dermatol; 1998 Jan; 134(1):104-6. PubMed ID: 9449922
    [No Abstract]   [Full Text] [Related]  

  • 11. [Persistent lymphedema of the penis and scrotum after recurrent episodes of cellulitis and urethritis caused by Chlamydia trachomatis].
    Carlino A; Calzavara PG
    G Ital Dermatol Venereol; 1989 Jun; 124(6):303-5. PubMed ID: 2630439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary late-onset lymphedema.
    Holmes LB; Fields JP; Zabriskie JB
    Pediatrics; 1978 Apr; 61(4):575-9. PubMed ID: 662482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of lower extremity lymphedema treated with vascularized lymph node flap transfer with or without venous complications.
    Koide S; Lin CY; Chen C; Cheng MH
    J Surg Oncol; 2020 Jan; 121(1):129-137. PubMed ID: 31246288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective amputation of the toes in severe lymphedema of the lower leg: rationale and indications.
    Chen HC; Gharb BB; Salgado CJ; Rampazzo A; Xu E; Spanio di Spilimbergo S; Su S
    Ann Plast Surg; 2009 Aug; 63(2):193-7. PubMed ID: 19593107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent lymphangitis and cellulitis of the extremities.
    SHICK RM
    Med Clin North Am; 1949 Jul; 33():1089-98. PubMed ID: 18152420
    [No Abstract]   [Full Text] [Related]  

  • 16. Large or persistent lymphocyst increases the risk of lymphedema, lymphangitis, and deep vein thrombosis after retroperitoneal lymphadenectomy for gynecologic malignancy.
    Kondo E; Tabata T; Shiozaki T; Motohashi T; Tanida K; Okugawa T; Ikeda T
    Arch Gynecol Obstet; 2013 Sep; 288(3):587-93. PubMed ID: 23455541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of cellulitis in a lymphedematous extremity: a case report.
    Connor MP; Gamelli R
    Cases J; 2009 Dec; 2():9377. PubMed ID: 20062550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Access to Specialists and History of Cellulitis Among Patients with Lymphedema: Secondary Analysis Using the National LIMPRINT Database.
    Dai M; Nakagami G; Sato A; Koyanagi H; Kohta M; Moffatt CJ; Murray S; Franks PJ; Sanada H; Sugama J
    Lymphat Res Biol; 2021 Oct; 19(5):442-446. PubMed ID: 34582714
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined conservative treatment and lymphatic venous anastomosis for severe lower limb lymphedema with recurrent cellulitis.
    Mihara M; Hara H; Tsubaki H; Suzuki T; Yamada N; Kawahara M; Murai N
    Ann Vasc Surg; 2015 Aug; 29(6):1318.e11-5. PubMed ID: 26146234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent Onsets of Cellulitis in Lower Limbs with Lymphedema Following COVID-19 mRNA Vaccination.
    Okazaki T; Matashiro M; Kodama G; Tshubota T; Furusawa Y; Izumi SI
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.